PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Vite Naturals (VN) is a plant-based nutrition brand that seeks to disrupt the $750 billion health and wellness food market. The company intends to target the aforementioned market with its products namely, Vite Brain, Vite Body, and Vite Protein +. Since launching its first product in late 2018, VN has sold directly to over 10,000 customers and accumulated hundreds of five-star reviews. VN has stocked its products with Holland Barretts both online and offline. The company earned £501,000 in revenue in 2020 and has positioned itself in rapid growth sectors. VN, in recent months, introduced products like 'Gut Health' and 'Mental Performance' in the snack bar category and listed with two of the UK’s largest health food distributors. The company states it will use the investment for new product development, optimising field sales, hiring marketing staff, launching brand awareness campaigns, and ensuring steady working capital.
days to go:
Expired
investment:
£167,020
Bazar is the UK’s first dedicated ethical marketplace and lifestyle application. The company intends to disrupt the ~£32.8 billion UK consumer marketplace by creating a platform where eco-friendly businesses can thrive, and consumers can trust brand values. It brings curated ethical and eco-friendly brands, artisans, and items under one portal. BAZAR soft-launched its application with 35 sellers and 650 products in the COVID-19 lockdown which doubled showing positive seller demand. The app saw over 1800 downloads with early sales. The company has a social media presence with over 1500+ Instagram followers. It intends to enter the US market in 2022, followed by Europe. Bazar will use the investment to continue to develop its technology to help sellers grow their business and give buyers an intuitive shopping experience on the app.
days to go:
Expired
investment:
£208,368
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
PlusGuidance is an online counselling/therapy platform that gives people immediate access to counselling. It provides secure video, voice, IM and email sessions directly through the site, and booking in-person sessions too. Our Mission - Immediate access to counselling for everyone. Business Model - Software-as-a-Service for counsellors, who pay a monthly fee to use secure online sessions, practice management tools to manage their clients, and a public web profile in our directory.
days to go:
Expired
investment:
£64,987
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Feastr is a UK-based multi-brand cloud kitchen business that delivers restaurant-quality food to a customer's doorstep in 30 minutes or less. The company asserts that operating from cloud kitchens within densely populated areas allows it to exploit the booming food delivery market without the huge overheads associated with bricks and mortar restaurants. Feastr operates its restaurants on aggregators such as Deliveroo, Uber Eats, and Just Eat, capitalising on their huge ready customer base. The company has had sales of over £550,000 since its launch in November 2019. It will use the investment to open three new locations, push its digital marketing campaign with new ideas in 2021, and prepare for its next round of fundraising.
days to go:
Expired
investment:
£346,487
